PGHL

Procter & Gamble Health, a midcap player in the Pharmaceuticals & Drugs industry, has recently experienced a shift in its technical trend from mildly bullish to a sideways movement. The company's current stock price stands at 4,996.95, down from a previous close of 5,285.00. Over the past year, the stock has seen a high of 5,835.95 and a low of 4,640.30, with today's trading reflecting a high of 5,258.00 and a low of 4,916.50. The technical summary indicates a mixed outlook. The MACD shows a mildly bearish trend on a weekly basis while remaining bullish on a monthly scale. The Relative Strength Index (RSI) shows no signals for both weekly and monthly periods. Bollinger Bands and KST indicate bearish trends on both weekly and monthly charts. Moving averages suggest a mildly bullish stance on a daily basis, while the On-Balance Volume (OBV) reflects a mildly bullish trend weekly but a bearish trend monthly. In terms of returns, Procter & Gamble Health has underperformed compared to the Sensex over various periods. The stock has returned -5.63% over the past week and -4.70% over the past month, while the Sensex returned -2.81% and -3.56%, respectively. Year-to-date, the stock is down 4.46%, compared to a 6.32% decline in the Sensex. However, over a longer horizon, the company has shown a 497.36% return over the past decade, significantly outperforming the Sensex's 149.30% return in the same period.